FDA Has Many Hurdles to Overcome in its Effort to Stem the Current Opioid...
The FDA has made many efforts to deal with the current opioid addiction crisis. The latest is the establishment of a "Opioid Policy Steering Committee." Some of these efforts may have...
Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But Pharmaceutical Marketers Can...
Almost two decades after the human genome was sequenced, a trickle of new genetic medicines (i.e., those that modify the expression of an individual’s genes or repair abnormal genes) has entered...
Farewell Pharma Friends! Beware of the PharmaGovernment Complex!
It's my 71st birthday and I decided it's a good time for me to move on to a new role. Unbelievable, right? John "PharmaGuy" Mack is seventy-one years old!
Also unbelievable is...
The Forgotten eHealth Code of Ethics
Recently, I was sorry to see that the eHealth Code of Ethics, which I helped create back in 2000, was not included in the list of references to an article about...
5 Trends That Will Shape Pharma Marketing in 2021
Originally Published by Intouch Group
Throughout the year 2020, pharma marketers were forced to explore new strategies in order to keep up with the many evolving trends. Pharma marketers have quickly learned...
Sexy Reps Sell Rx Drugs
"Known for their athleticism, postage-stamp skirts and persuasive enthusiasm, cheerleaders have many qualities the drug industry looks for in its sales force," according to an article in today's New York Times...
Why Has There Been a Drop in FDA Enforcement Activity?
That's one question on the mind of EyeOnFDA author Mark Senak of FleishmanHillard's Washington, D.C. office. Senak plotted the number of "Action Letters," which are Warning Letters to drug company CEOs...
Tactical Overload…Building a Linear & Cohesive Brand Plan
Overview:
Frequently teams complicate brand plans by focusing on breadth tactics over depth of insight. Often it would be best to limit the focus, through a richer understanding of what is...
Why the FDA Approved Zohydro
The opiate Zohydro was approved by the FDA although that decision went against the recommendation of the agency’s own advisory panel, which voted 11 to 2 against approving the drug because...
Digital Health Publishers Just Got a Healthy Way to Drive New Visits
It’s no secret that digital health publishers of all types struggle to introduce new users to their content. Consumer traffic exchanges and content discovery engines have historically focused on every vertical except health and medicine. You can easily find dozens of networks that focus on fashion, sports, pop culture, technology or finance, but consumer health is MIA.
